Review of Lung Cancer Quality Performance Indicators: consultation

A consultation on the revised Lung Cancer Quality Performance Indicators (QPIs), which were revised following a formal review.


Footnotes

a Stage IIIA NSCLC includes: T1a N2; T1b N2; T2a N2; T2b N2; T3 N1; T3 N2; T4 N0; T4 N1

b Patients with T xN 1-3M o disease will be included within the measurement of this QPI.

c Active treatment includes:

  • Surgery
  • Radical radiotherapy (> 54Gy)
  • Adjuvant Chemotherapy
  • Chemoradiotherapy
  • Palliative Chemotherapy/ Biological Therapy

Contact

Back to top